Cargando…
Disseminated Tuberculosis in a Psoriasis Patient under Adalimumab Treatment despite the Chemoprophylaxis of Latent Tuberculosis: A Case Report
Recently, biologic therapy has become a major advance in the management of moderate-to-severe psoriasis. Although the overall safety profile of biologics is favorable, primary infection or reactivation of latent tuberculosis (TB) is the major concern in the setting of tumor necrosis factor-alpha inh...
Autores principales: | Oh, Jae Hong, Ham, Seung Pil, Park, Hai-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Dermatological Association; The Korean Society for Investigative Dermatology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875218/ https://www.ncbi.nlm.nih.gov/pubmed/33911816 http://dx.doi.org/10.5021/ad.2021.33.1.77 |
Ejemplares similares
-
Development of Disseminated Tuberculosis with Intestinal Involvement due to Adalimumab Administration Despite Latent Tuberculosis Treatment
por: Ikuta, Kozo, et al.
Publicado: (2019) -
Disseminated Tuberculosis Associated With Adalimumab Therapy
por: Silva, Marinha, et al.
Publicado: (2021) -
A Systematic Review of Economic Evaluations of Chemoprophylaxis for Tuberculosis
por: Chavan, Shraddha, et al.
Publicado: (2011) -
Tuberculosis Infection and Latent Tuberculosis
por: Lee, Seung Heon
Publicado: (2016) -
Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis
por: Ribero, Simone, et al.
Publicado: (2019)